EyePoint Pharmaceuticals, Inc.·4

Aug 21, 4:32 PM ET

DICICCO WENDY F 4

4 · EyePoint Pharmaceuticals, Inc. · Filed Aug 21, 2024

Insider Transaction Report

Form 4
Period: 2024-08-20
Transactions
  • Purchase

    Common Stock

    2024-08-20$7.79/sh+2,567$19,9979,967 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.77 to $7.81. The reporting person undertakes to provide EyePoint Pharmaceuticals Inc., any security holder of EyePoint Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT